Listing on New York S.E.

SMITH & NEPHEW PLC
7 October 1999



Commenting on the forthcoming NYSE listing, Chris O'Donnell, Chief Executive,
said 'Smith & Nephew is a global leader in its medical device markets.  Our
listing will increase Smith & Nephew's visibility in the US healthcare market
and enable the company to capitalise on the growing interest there in both
healthcare technology and international securities.  We want to make sure that
US investors and our employees have the opportunity to participate in Smith &
Nephew's success.

During this week the Company is briefing US analysts ahead of this announcement.